Resolution (%) | OR (95% CI) | ||||
---|---|---|---|---|---|
Clinical condition | Type of reminder | Total | Control group | Intervention group | |
Type 2 diabetes mellitus | Screen for diabetic retinopathy | 23.88 | 20.05 | 27.52 | 1.51 (1.46–1.57) |
Measure glycated hemoglobin | 26.23 | 25.32 | 27.11 | 1.1 (1.07–1.13) | |
Heart failure/ischemic heart disease | Treat with beta blocker | 14.64 | 12.58 | 16.61 | 1.38 (1.32–1.44) |
Heart failure | Treat with ACEI/ARB | 24.53 | 21.51 | 27.35 | 1.37 (1.27–1.48) |
High blood pressure | Measure blood pressure | 30.19 | 27 | 33.24 | 1.35 (1.33–1.36) |
Hepatitis C | Hepatitis B vaccine | 5.59 | 4.99 | 6.2 | 1.26 (1.1–1.43) |
Atrial fibrillation | Treat with antiplatelet drug/anticoagulant | 31.41 | 28.97 | 33.76 | 1.25 (1.15–1.36) |
Cerebrovascular accident/ischemic heart disease | Treat with antiplatelet drug | 33.32 | 30.75 | 35.72 | 1.25 (1.18–1.32) |
Measure LDL cholesterol | 27.19 | 25.71 | 28.63 | 1.16 (1.13–1.19) | |
Smoking | Encourage smoking cessation | 12.04 | 11.42 | 12.66 | 1.12 (1.09–1.16) |